Anebulo Pharmaceuticals Inc (ANEB)
1.48
-0.02
(-1.33%)
USD |
NASDAQ |
Nov 22, 15:02
Anebulo Pharmaceuticals Market Cap: 38.38M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 38.90M |
| November 20, 2024 | 39.42M |
| November 19, 2024 | 39.42M |
| November 18, 2024 | 39.68M |
| November 15, 2024 | 41.19M |
| November 14, 2024 | 39.42M |
| November 13, 2024 | 40.20M |
| November 12, 2024 | 42.79M |
| November 11, 2024 | 43.83M |
| November 08, 2024 | 42.27M |
| November 07, 2024 | 38.12M |
| November 06, 2024 | 48.50M |
| November 05, 2024 | 47.72M |
| November 04, 2024 | 49.01M |
| November 01, 2024 | 47.72M |
| October 31, 2024 | 48.75M |
| October 30, 2024 | 47.98M |
| October 29, 2024 | 49.14M |
| October 28, 2024 | 47.46M |
| October 25, 2024 | 47.46M |
| October 24, 2024 | 49.27M |
| October 23, 2024 | 49.01M |
| October 22, 2024 | 47.73M |
| October 21, 2024 | 48.24M |
| October 18, 2024 | 50.87M |
| Date | Value |
|---|---|
| October 17, 2024 | 47.46M |
| October 16, 2024 | 49.01M |
| October 15, 2024 | 49.27M |
| October 14, 2024 | 47.46M |
| October 11, 2024 | 48.75M |
| October 10, 2024 | 48.50M |
| October 09, 2024 | 50.57M |
| October 08, 2024 | 49.01M |
| October 07, 2024 | 49.67M |
| October 04, 2024 | 50.57M |
| October 03, 2024 | 49.53M |
| October 02, 2024 | 51.35M |
| October 01, 2024 | 51.47M |
| September 30, 2024 | 50.05M |
| September 27, 2024 | 53.16M |
| September 26, 2024 | 50.83M |
| September 25, 2024 | 47.98M |
| September 24, 2024 | 54.20M |
| September 23, 2024 | 57.57M |
| September 20, 2024 | 79.87M |
| September 19, 2024 | 53.94M |
| September 18, 2024 | 51.87M |
| September 17, 2024 | 58.87M |
| September 16, 2024 | 54.20M |
| September 13, 2024 | 53.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
38.12M
Minimum
Nov 07 2024
208.23M
Maximum
May 21 2021
92.55M
Average
73.19M
Median
Market Cap Benchmarks
| Revance Therapeutics Inc | 398.63M |
| NovaBay Pharmaceuticals Inc | 3.444M |
| Palatin Technologies Inc | 18.97M |
| iBio Inc | 24.43M |
| Theriva Biologics Inc | 3.589M |
Market Cap Related Metrics
| Price to Book Value | 20.21 |
| Price | 1.48 |
| Earnings Yield | -20.27% |